Silver Spring, Marland—(ENEWSPF)—September 12, 2013. The U.S. Food and Drug Administration yesterday approved a new use for Botox Cosmetic (onabotulinumtoxinA) for the temporary improvement in the appearance of moderate to severe lateral canthal lines, known as crow’s feet, in adults. Botox Cosmetic is the only FDA approved drug treatment option for lateral canthal lines.
